Search Results for "New York Times Duke University Cancer Genetics"
Matching Channels
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common ca...
Tumor Immunology is a field of medical science developing to understand tumors, and use the body natural immune system to develop new anti-cancer treatments. Cancer is arguably one of the most impor...
Prostate cancer is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostate ca...
Personalized medicines are a new therapeutic option that takes into account the genetics and individuality of patients diseases, and then develops or prescribes drug that are likely to have the most...
According to the American Brain Tumor Association, just over 24,000 patients will be diagnosed with a primary malignant brain tumour during 2012 in the US alone. Some 80% of primary malignant brain...
Matching News
Duke epigenetic analysis of stomach cancer finds new disease subtypes
Researchers at the Duke-NUS Graduate Medical School in Singapore have identified numerous new subtypes of gastric cancer that are triggered by environmental factors. The researchers used 240 primary t...
Duke-led genome sequencing of Burkitt lymphoma reveals unique mutation
In the first broad genetic landscape mapped of a Burkitt lymphoma tumor, scientists at Duke Medicine (home to the Duke Cancer Institute) and their collaborators identified 70 mutations, including seve...
Cancer Genetics amends IPO again
Cancer Genetics Inc. (Rutherford, N.J.) again amended its IPO, lowering to 600,000 the number of shares it plans to sell at $10-$12. An $11 price would raise $6.6 million and value the cancer diagnost...
Hollywood Celebrates Breast Cancer Genetics Pioneer Mary-Claire King
A sort of perfect storm of celebrity and media has hit the world of breast-cancer genetics. Actress and international celebrity Angelina Jolie wrote yesterday in The New York Times of her own genetic...
Cancer study points to tighter pairing of drugs and patients
The first large and comprehensive study of the genetics of a common lung cancer has found that more than half the tumors from that cancer have mutations that might be treated by new drugs that are al...
Policy Paper: Myriad turns cancer genetic data into trade secrets
If the information Myriad Genetics has collected about breast cancer mutations remains proprietary, costs of gene tests could increase while quality declines, argues Robert Cook-Deegan, a policy res...
Duke researchers describe how breast cancer cells acquire drug resistance
(Duke University Medical Center) A seven-year quest to understand how breast cancer cells resist treatment with the targeted therapy lapatinib has revealed a previously unknown molecular network that...
Cancer Genetics again amends IPO
Cancer Genetics Inc. (Rutherford, N.J.) amended its IPO and now plans to sell 5 million shares at $4-$6. A $5 price would raise $25 million and value the cancer diagnostics company at $65 million. Aeg...
Matching PubMed Articles
Histone H3K4 methylation keeps centromeres open for business.
Novel Insights Into Beta-Blocker Therapy for Long QT Syndromes.
Can polymorphisms predict response to antiarrhythmic drugs in atrial fibrillation?
Prostate cancer: Making the switch from LHRH antagonist to LHRH agonist.
